Assessing the prognostic value of long non-coding RNAs in glioblastoma patients: findings from a systematic review and meta-analysis

Abstract Background Glioblastoma multiforme (GBM) is an exceedingly aggressive tumor subtype, comprising 60% of high-grade gliomas and 54% of all gliomas. GBM has poor survival rates despite current treatments, with less than 5% of patients surviving beyond five years. Long Non-coding RNAs (LncRNAs)...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zahra Jamalpoor, Amir Hossein Aghayan, Ebrahim Mirzaei, Davood Mohammadi, Amir Atashi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-11-01
coleção:	Cancer Cell International
Assuntos:	Glioblastoma multiforme GBM Long non-coding RNAs LncRNAs Overall survival
Acesso em linha:	https://doi.org/10.1186/s12935-025-04051-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!